GLYC: Bathi resik saben saham sajrone 12 wulan pungkasan GlycoMimetics, Inc.

GlycoMimetics, Inc. (GLYC) develops targeted carbohydrate mimetics to combat leukemia, relying heavily on patents and FDA verdicts. The EPS trend over the last 12 months illustrates this volatility, where the value -0.46 represents the current figure. A lack of revenue and trial uncertainty leave the company vulnerable, while its environmental strategy is limited solely to the proper disposal of laboratory waste.

GLYC (GlycoMimetics, Inc.) riwayat Bathi resik saben saham (EPS TTM) saka 04.07.2022 nganti 16.06.2025

Rincian analitis perusahaan GlycoMimetics, Inc.

- rega saham lan prakiraan rega para ahli:

Kutipan saham GlycoMimetics Corp|GLYC - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Biji pasar GlycoMimetics, Inc.|GLYC - Total Nilai Bisnis

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham GlycoMimetics|GLYC - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku glycomimetics.com|GLYC - Nilai Agregat Aset

- rincian struktur utang lan likuiditas bisnis:

Total Utang marang Modal GlycoMimetics, Inc.|GLYC - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal GlycoMimetics Corp|GLYC - Utang kumulatif perusahaan|Utang marang nilai buku GlycoMimetics, Inc.|GLYC - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan GlycoMimetics|Rasio cepet glycomimetics.com

- indikator pendapatan resik lan kelipatan nilai:

GLYC - Bathi perusahaan|Bathi mangsa ngarep GlycoMimetics, Inc.|GLYC - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi GlycoMimetics Corp|GLYC - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA GlycoMimetics, Inc.|GLYC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) GlycoMimetics|GLYC - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan glycomimetics.com|GLYC - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep GlycoMimetics, Inc.

- data dodolan lan asil:

GLYC - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan GlycoMimetics Corp|GLYC - Rasio rega marang dodolan|Multiplikator forward rega marang pendapatan GlycoMimetics, Inc.

Analisis dhasar perusahaan:glycomimetics.com - GLYC

Produk sing diprodhuksi GlycoMimetics Inc.

Asset quality is assessed through the actual yield of each share. This metric calculates the total annual net income divided by the total number of securities. By analyzing the TTM fundamental earnings per share trend, an investor identifies hidden financial risks. For GlycoMimetics, Inc. (GLYC), this indicator reflects the cost efficiency of developing oncology drugs. Scientific synergy with medical centers should convert into growth for this metric.

Karo sapa GlycoMimetics, Inc. saingan